Centerpoint Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.01M | Sell |
3,965
-210
| -5% | -$48.9K | 0.29% | 36 |
|
|
2026
Q1 | $1.02M | Sell |
4,175
-1,355
| -25% | -$316K | 0.33% | 35 |
|
|
2025
Q4 | $1.14M | Sell |
5,530
-158
| -3% | -$31.2K | 0.35% | 36 |
|
|
2025
Q3 | $1.05M | Sell |
5,688
-89
| -2% | -$15.2K | 0.33% | 37 |
|
|
2025
Q2 | $882K | Sell |
5,777
-471
| -8% | -$72.4K | 0.3% | 37 |
|
|
2025
Q1 | $1.04M | Sell |
6,248
-1,210
| -16% | -$189K | 0.38% | 33 |
|
|
2024
Q4 | $1.08M | Sell |
7,458
-270
| -3% | -$41.8K | 0.38% | 35 |
|
|
2024
Q3 | $1.25M | Sell |
7,728
-3,264
| -30% | -$520K | 0.44% | 27 |
|
|
2024
Q2 | $1.61M | Sell |
10,992
-1,196
| -10% | -$178K | 0.58% | 24 |
|
|
2024
Q1 | $1.93M | Sell |
12,188
-187
| -2% | -$29.8K | 0.72% | 22 |
|
|
2023
Q4 | $1.94M | Sell |
12,375
-13
| -0.1% | -$1.99K | 0.76% | 22 |
|
|
2023
Q3 | $1.93M | Buy |
12,388
+272
| +2% | +$44.9K | 0.82% | 22 |
|
|
2023
Q2 | $2M | Sell |
12,116
-1,676
| -12% | -$271K | 0.81% | 21 |
|
|
2023
Q1 | $2.14M | Buy |
13,792
+25
| +0.2% | +$4.04K | 0.93% | 19 |
|
|
2022
Q4 | $2.43M | Buy |
13,767
+336
| +3% | +$58K | 1.14% | 19 |
|
|
2022
Q3 | $2.19M | Sell |
13,431
-847
| -6% | -$143K | 1.17% | 18 |
|
|
2022
Q2 | $2.54M | Buy |
14,278
+869
| +6% | +$155K | 1.29% | 18 |
|
|
2022
Q1 | $2.38M | Buy |
13,409
+1,692
| +14% | +$288K | 1.09% | 20 |
|
|
2021
Q4 | $2M | Buy |
11,717
+2,876
| +33% | +$471K | 0.88% | 20 |
|
|
2021
Q3 | $1.43M | Sell |
8,841
-125
| -1% | -$21.3K | 0.68% | 22 |
|
|
2021
Q2 | $1.48M | Buy |
8,966
+7,484
| +505% | +$1.24M | 0.7% | 22 |
|
|
2021
Q1 | $244K | Buy |
1,482
+1
| +0.1% | +$162 | 0.14% | 49 |
|
|
2020
Q4 | $233K | Buy |
1,481
+98
| +7% | +$14.5K | 0.15% | 44 |
|
|
2020
Q3 | $206K | Hold |
1,383
| – | – | 0.16% | 44 |
|
|
2020
Q2 | $194K | Buy |
1,383
+1
| +0.1% | +$146 | 0.16% | 45 |
|
|
2020
Q1 | $181K | Sell |
1,382
-512
| -27% | -$72.6K | 0.18% | 34 |
|
|
2019
Q4 | $276K | Buy |
1,894
+1
| +0.1% | +$136 | 0.2% | 37 |
|
|
2019
Q3 | $245K | Hold |
1,893
| – | – | 0.19% | 37 |
|
|
2019
Q2 | $264K | Buy |
1,893
+100
| +6% | +$13.8K | 0.21% | 38 |
|
|
2019
Q1 | $251K | Hold |
1,793
| – | – | 0.21% | 38 |
|
|
2018
Q4 | $231K | Sell |
1,793
-2,480
| -58% | -$346K | 0.22% | 37 |
|
|
2018
Q3 | $590K | Sell |
4,273
-160
| -4% | -$21.3K | 0.47% | 19 |
|
|
2018
Q2 | $538K | Buy |
4,433
+30
| +0.7% | +$3.74K | 0.45% | 19 |
|
|
2018
Q1 | $564K | Buy |
4,403
+3,020
| +218% | +$408K | 0.49% | 18 |
|
|
2017
Q4 | $193K | Buy |
+1,383
| New | +$193K | 0.17% | 34 |
|
Other funds holding JNJ
Centerpoint Advisors's JNJ Position: Q2 2026 in Review
Centerpoint Advisors reduced its Johnson & Johnson (JNJ) stake by 5% in Q2 2026, selling an estimated $48.9K and leaving 3,965 shares worth $1.01M. The position accounts for 0.29% of the portfolio, ranked #36.
Centerpoint Advisors first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.54M in Q2 2022. 4,678 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Centerpoint Advisors held 3,965 shares of Johnson & Johnson worth $1.01M as of Q2 2026.
- Centerpoint Advisors sold 210 Johnson & Johnson shares in Q2 2026, an estimated $48.9K.
- Johnson & Johnson made up 0.29% of Centerpoint Advisors's portfolio in Q2 2026, its #36 holding.
- Centerpoint Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
- Centerpoint Advisors's Johnson & Johnson position peaked at $2.54M in Q2 2022.
- 4,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.